Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | FBXO2 | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | Fbxo2 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of FBXO2 mRNA] | CTD | PMID:22206623 | FBXO2 | Human | 1,2-dimethylhydrazine | decreases expression | ISO | Fbxo2 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of FBXO2 mRNA | CTD | PMID:22206623 | FBXO2 | Human | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of FBXO2 mRNA | CTD | PMID:31614463 | FBXO2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FBXO2 mRNA | CTD | PMID:20106945 and PMID:21632981 | FBXO2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Fbxo2 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FBXO2 mRNA | CTD | PMID:33387578 | FBXO2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of FBXO2 mRNA | CTD | PMID:22298810 and PMID:22574217 | FBXO2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Fbxo2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of FBXO2 mRNA | CTD | PMID:21570461 | FBXO2 | Human | 2-methoxyethanol | decreases expression | ISO | Fbxo2 (Rattus norvegicus) | 6480464 | methyl cellosolve results in decreased expression of FBXO2 mRNA | CTD | PMID:19643169 | FBXO2 | Human | 6-propyl-2-thiouracil | decreases expression | ISO | Fbxo2 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of FBXO2 mRNA | CTD | PMID:24780913 | FBXO2 | Human | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of FBXO2 mRNA | CTD | PMID:27153756 | FBXO2 | Human | ammonium chloride | affects expression | ISO | Fbxo2 (Rattus norvegicus) | 6480464 | Ammonium Chloride affects the expression of FBXO2 mRNA | CTD | PMID:16483693 | FBXO2 | Human | antirheumatic drug | affects expression | EXP | | 6480464 | Antirheumatic Agents affects the expression of FBXO2 mRNA | CTD | PMID:24449571 | FBXO2 | Human | atrazine | increases expression | EXP | | 6480464 | Atrazine results in increased expression of FBXO2 mRNA | CTD | PMID:22378314 | FBXO2 | Human | benzo[a]pyrene | decreases expression | ISO | Fbxo2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of FBXO2 mRNA | CTD | PMID:19770486 | FBXO2 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of FBXO2 3' UTR | CTD | PMID:27901495 | FBXO2 | Human | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of FBXO2 mRNA | CTD | PMID:20106945 more ... | FBXO2 | Human | benzo[a]pyrene | increases expression | ISO | Fbxo2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of FBXO2 mRNA | CTD | PMID:22228805 | FBXO2 | Human | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | Fbxo2 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of FBXO2 promoter | CTD | PMID:23359474 | FBXO2 | Human | bisphenol A | multiple interactions | ISO | Fbxo2 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of FBXO2 promoter | CTD | PMID:23359474 | FBXO2 | Human | bisphenol A | increases expression | ISO | Fbxo2 (Mus musculus) | 6480464 | bisphenol A results in increased expression of FBXO2 mRNA | CTD | PMID:32156529 | FBXO2 | Human | bisphenol A | decreases expression | ISO | Fbxo2 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of FBXO2 mRNA | CTD | PMID:35598803 | FBXO2 | Human | bisphenol A | increases methylation | ISO | Fbxo2 (Mus musculus) | 6480464 | bisphenol A results in increased methylation of FBXO2 promoter | CTD | PMID:27312807 | FBXO2 | Human | bisphenol A | increases methylation | ISO | Fbxo2 (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of FBXO2 gene | CTD | PMID:28505145 | FBXO2 | Human | bisphenol A | decreases expression | ISO | Fbxo2 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of FBXO2 mRNA | CTD | PMID:25181051 and PMID:34947998 | FBXO2 | Human | C60 fullerene | decreases expression | ISO | Fbxo2 (Rattus norvegicus) | 6480464 | fullerene C60 results in decreased expression of FBXO2 mRNA | CTD | PMID:19167457 | FBXO2 | Human | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of FBXO2 mRNA | CTD | PMID:26472689 | FBXO2 | Human | calcitriol | increases expression | EXP | | 6480464 | Calcitriol results in increased expression of FBXO2 mRNA | CTD | PMID:26485663 | FBXO2 | Human | chrysene | decreases expression | ISO | Fbxo2 (Mus musculus) | 6480464 | chrysene results in decreased expression of FBXO2 mRNA | CTD | PMID:26377693 | FBXO2 | Human | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of FBXO2 mRNA | CTD | PMID:27392435 | FBXO2 | Human | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of FBXO2 mRNA | CTD | PMID:27392435 | FBXO2 | Human | copper(II) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of FBXO2 mRNA | CTD | PMID:19549813 | FBXO2 | Human | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of FBXO2 mRNA | CTD | PMID:20106945 | FBXO2 | Human | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of FBXO2 mRNA | CTD | PMID:27989131 | FBXO2 | Human | cytarabine | decreases expression | EXP | | 6480464 | Cytarabine results in decreased expression of FBXO2 mRNA | CTD | PMID:21198554 | FBXO2 | Human | dextran sulfate | increases expression | ISO | Fbxo2 (Mus musculus) | 6480464 | Dextran Sulfate results in increased expression of FBXO2 mRNA | CTD | PMID:35093514 | FBXO2 | Human | diazinon | decreases methylation | EXP | | 6480464 | Diazinon results in decreased methylation of FBXO2 gene | CTD | PMID:22964155 | FBXO2 | Human | dibutyl phthalate | multiple interactions | ISO | Fbxo2 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of FBXO2 promoter | CTD | PMID:23359474 | FBXO2 | Human | dicrotophos | decreases expression | EXP | | 6480464 | dicrotophos results in decreased expression of FBXO2 mRNA | CTD | PMID:28302478 | FBXO2 | Human | dieldrin | affects expression | ISO | Fbxo2 (Rattus norvegicus) | 6480464 | Dieldrin affects the expression of FBXO2 mRNA | CTD | PMID:22546817 | FBXO2 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | FBXO2 | Human | elemental selenium | increases expression | EXP | | 6480464 | Selenium results in increased expression of FBXO2 mRNA | CTD | PMID:19244175 | FBXO2 | Human | endosulfan | affects expression | ISO | Fbxo2 (Rattus norvegicus) | 6480464 | Endosulfan affects the expression of FBXO2 protein | CTD | PMID:31464424 | FBXO2 | Human | endosulfan | increases expression | ISO | Fbxo2 (Rattus norvegicus) | 6480464 | Endosulfan results in increased expression of FBXO2 mRNA | CTD | PMID:31464424 | FBXO2 | Human | entinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FBXO2 mRNA | CTD | PMID:27188386 | FBXO2 | Human | entinostat | increases expression | EXP | | 6480464 | entinostat results in increased expression of FBXO2 mRNA | CTD | PMID:26272509 and PMID:27188386 | FBXO2 | Human | ethanol | multiple interactions | EXP | | 6480464 | [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of FBXO2 mRNA | CTD | PMID:29432896 | FBXO2 | Human | ethanol | increases expression | ISO | Fbxo2 (Mus musculus) | 6480464 | Ethanol results in increased expression of FBXO2 mRNA | CTD | PMID:30319688 | FBXO2 | Human | flavonoids | increases expression | ISO | Fbxo2 (Rattus norvegicus) | 6480464 | Flavonoids results in increased expression of FBXO2 mRNA | CTD | PMID:18035473 | FBXO2 | Human | folic acid | multiple interactions | ISO | Fbxo2 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of FBXO2 mRNA] | CTD | PMID:22206623 | FBXO2 | Human | gentamycin | increases expression | ISO | Fbxo2 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of FBXO2 mRNA | CTD | PMID:33387578 | FBXO2 | Human | isobutanol | multiple interactions | EXP | | 6480464 | [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of FBXO2 mRNA | CTD | PMID:29432896 | FBXO2 | Human | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of FBXO2 protein | CTD | PMID:32959892 | FBXO2 | Human | ketamine | increases expression | ISO | Fbxo2 (Rattus norvegicus) | 6480464 | Ketamine results in increased expression of FBXO2 mRNA | CTD | PMID:20080153 | FBXO2 | Human | lead(0) | decreases expression | EXP | | 6480464 | Lead results in decreased expression of FBXO2 mRNA | CTD | PMID:19921347 | FBXO2 | Human | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | increases expression | ISO | Fbxo2 (Mus musculus) | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of FBXO2 mRNA | CTD | PMID:25566086 | FBXO2 | Human | nickel dichloride | affects expression | ISO | Fbxo2 (Rattus norvegicus) | 6480464 | nickel chloride affects the expression of FBXO2 mRNA | CTD | PMID:22546817 | FBXO2 | Human | niclosamide | increases expression | EXP | | 6480464 | Niclosamide results in increased expression of FBXO2 mRNA | CTD | PMID:36318118 | FBXO2 | Human | ozone | multiple interactions | ISO | Fbxo2 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of FBXO2 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of FBXO2 mRNA | CTD | PMID:34911549 | FBXO2 | Human | panobinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FBXO2 mRNA | CTD | PMID:27188386 | FBXO2 | Human | panobinostat | increases expression | EXP | | 6480464 | panobinostat results in increased expression of FBXO2 mRNA | CTD | PMID:26272509 | FBXO2 | Human | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of FBXO2 mRNA | CTD | PMID:29067470 | FBXO2 | Human | paracetamol | increases expression | ISO | Fbxo2 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of FBXO2 mRNA | CTD | PMID:33387578 | FBXO2 | Human | perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of FBXO2 protein | CTD | PMID:26879310 | FBXO2 | Human | propanal | increases expression | EXP | | 6480464 | propionaldehyde results in increased expression of FBXO2 mRNA | CTD | PMID:26079696 | FBXO2 | Human | quercetin | increases expression | EXP | | 6480464 | Quercetin results in increased expression of FBXO2 mRNA | CTD | PMID:21632981 | FBXO2 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | FBXO2 | Human | selenium atom | increases expression | EXP | | 6480464 | Selenium results in increased expression of FBXO2 mRNA | CTD | PMID:19244175 | FBXO2 | Human | serpentine asbestos | increases expression | EXP | | 6480464 | Asbestos and Serpentine results in increased expression of FBXO2 mRNA | CTD | PMID:21148743 | FBXO2 | Human | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide analog results in decreased expression of FBXO2 mRNA | CTD | PMID:25895662 | FBXO2 | Human | silver atom | increases expression | ISO | Fbxo2 (Mus musculus) | 6480464 | Silver results in increased expression of FBXO2 mRNA | CTD | PMID:27131904 | FBXO2 | Human | silver(0) | increases expression | ISO | Fbxo2 (Mus musculus) | 6480464 | Silver results in increased expression of FBXO2 mRNA | CTD | PMID:27131904 | FBXO2 | Human | Soman | increases expression | ISO | Fbxo2 (Rattus norvegicus) | 6480464 | Soman results in increased expression of FBXO2 mRNA | CTD | PMID:19281266 | FBXO2 | Human | sulforaphane | decreases expression | EXP | | 6480464 | sulforaphane results in decreased expression of FBXO2 mRNA | CTD | PMID:31838189 | FBXO2 | Human | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of FBXO2 mRNA | CTD | PMID:31533062 | FBXO2 | Human | T-2 toxin | affects expression | ISO | Fbxo2 (Rattus norvegicus) | 6480464 | T-2 Toxin affects the expression of FBXO2 protein | CTD | PMID:26141394 | FBXO2 | Human | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of FBXO2 mRNA | CTD | PMID:24935251 | FBXO2 | Human | triclosan | increases expression | EXP | | 6480464 | Triclosan results in increased expression of FBXO2 mRNA | CTD | PMID:30510588 | FBXO2 | Human | valproic acid | increases expression | ISO | Fbxo2 (Mus musculus) | 6480464 | Valproic Acid results in increased expression of FBXO2 mRNA | CTD | PMID:21427059 | FBXO2 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of FBXO2 mRNA | CTD | PMID:25979313 | FBXO2 | Human | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of FBXO2 gene | CTD | PMID:29154799 | FBXO2 | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of FBXO2 mRNA | CTD | PMID:19101580 more ... | FBXO2 | Human | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FBXO2 mRNA | CTD | PMID:27188386 | |